kr 511.50 ($50.72)

-2.00 (-0.39%)

Weekly Expected Move ±2.5%

kr 486 kr 499 kr 512 kr 524 kr 537

STO · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 33 · kr 7.7B mcap · 12M float · 0.135% daily turnover

Revenue

$2.1B +16.7% ▲

5Y CAGR: +20.9%

Gross Profit

$321M -69.6% ▼

5Y CAGR: -0.3%

Operating Income

$300M +10.2% ▲

5Y CAGR: +27.5%

Net Income

$220M +6.0% ▲

5Y CAGR: +29.3%

EPS (Diluted)

$14.65 +4.6% ▲

5Y CAGR: +28.1%

EBITDA

$474M +19.7% ▲

5Y CAGR: +26.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$916M	$1.1B	$1.6B	$1.8B	$2.1B
YoY Growth	+12.1%	+21.3%	+42.8%	+13.8%	+16.7%
Cost of Revenue	$546M	$649M	$661M	$750M	$1.8B
Gross Profit	$370M	$462M	$926M	$1.1B	$321M
Gross Margin	40.4%	41.6%	58.4%	58.5%	15.2%
R&D Expenses	$20M	$34M	$14M	$44M	$58M
SG&A Expenses	$112M	-$22M	$685M	$698M	-$37M
Operating Expenses	$262M	$313M	$699M	$785M	$933M
Operating Income	$127M	$171M	$228M	$272M	$300M
Operating Margin	13.9%	15.4%	14.3%	15.1%	14.2%
Interest Expense	$9M	$16M	$16M	$19M	$32M
Income Before Tax	$117M	$152M	$222M	$262M	$289M
Tax Expense	$19M	$34M	$50M	$52M	$68M
Net Income	$96M	$118M	$172M	$207M	$220M
Net Margin	10.5%	10.6%	10.8%	11.5%	10.4%
EPS (Diluted)	$6.52	$7.94	$11.59	$14.00	$14.65
EBITDA	$192M	$237M	$342M	$396M	$474M
Shares Outstanding	15M	15M	15M	15M	15M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$413M	$474M	$494M	$522M	$502M	$591M	$557M	$606M
Cost of Revenue	$175M	$203M	$203M	$215M	$430M	$240M	$477M	$244M
Gross Profit	$238M	$271M	$291M	$307M	$71M	$351M	$79M	$363M
Gross Margin	57.6%	57.1%	59.0%	58.8%	14.2%	59.3%	14.2%	59.8%
R&D Expenses	$0	$44M	$0	$0	$0	$0	$0	$0
SG&A Expenses	$0	$192M	$0	$0	$0	$0	$0	$0
Operating Expenses	$172M	$214M	$224M	$231M	$0	$262M	$0	$261M
Operating Income	$66M	$57M	$67M	$76M	$71M	$89M	$79M	$102M
Operating Margin	15.9%	12.0%	13.5%	14.5%	14.2%	15.1%	14.2%	16.8%
Interest Expense	$4M	$6M	$5M	$7M	$8M	$14M	$13M	$14M
Income Before Tax	$65M	$53M	$65M	$70M	$68M	$85M	$71M	$90M
Tax Expense	$12M	$10M	$15M	$17M	$17M	$20M	$15M	$21M
Net Income	$53M	$42M	$50M	$54M	$51M	$65M	$56M	$69M
Net Margin	12.8%	8.8%	10.2%	10.3%	10.2%	10.9%	10.0%	11.4%
EPS (Diluted)	$3.50	$2.80	$3.37	$3.57	$3.41	$4.30	$3.72	$4.60
EBITDA	$99M	$89M	$102M	$111M	$111M	$150M	$123M	$149M
Shares Outstanding	15M	15M	15M	15M	15M	15M	15M	15M

MCAP.ST STO